Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Mocci G, Bodini G, Allegretta L, Cazzato AI, Chiri S, Aragona G, Perazzo P, Ferronato A, Graziani MG, Pagnini C, Zampaletta C, Graziosi C, Picchio M, Elisei W, Maconi G, Tursi A.
Mocci G, et al. Among authors: elisei w.
Biomedicines. 2022 Jul 26;10(8):1799. doi: 10.3390/biomedicines10081799.
Biomedicines. 2022.
PMID: 35892698
Free PMC article.